CARDIOMYO, the European consortium project led by ZeClinics and its partners Taros Chemicals and Amsterdam University Medical Centers, has been awarded with a budget of 2,4 million euros from the prestigious EUREKA- EUROSTARS innovation program.
Discovering the World of Chemistry
Discovery chemistry, custom synthesis and process development from lab to kg-/pilot scale for global pharmaceutical, biotech and chemical companies since 1999.
EFMC-ISMC 2021 will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, diseases of the brain, heart, and respiratory system, fibrotic diseases and cancer. EFMC-ISMC 2021 will also feature most recent advances in new technologies such as…
Which challenges do entrepreneurs face when setting up and establishing a CRO in Europe or Asia? This essential question will be answered by our CEO Dr. Dimitrios Tzalis in the Life Science Get2Gether (LSG2G) Podcast hosted by Christian Soschner.
The French Medicinal Chemistry Society is pleased to invite to the 56th edition of the International Conference on Medicinal Chemistry.
Discovery Chemistry services to materialize your ideas
We provide long-term added value to our diverse customers through discovery chemistry services and contract research
Our contract research focuses on holistic and cost-effective solutions of the highest quality for the global marketplace. We are inspired to provide exceptional added value to our customers’ R&D processes by anticipating hurdles foreseeing cost and lead time reductions. Thereby we facilitate competitive and “early-to-market” advantages. With our state-of-the-art lab facilities and our scientists (of which 65% hold a Ph.D. in Chemistry), we are committed to serve the diverse needs of our customers with discovery chemistry services in drug discovery, custom synthesis and specialty or performance chemicals. More than 13,000 synthesis, research and process chemistry projects have been delivered successfully to our ever-growing global customer base.